Topic: Cancer treatment
This project could significantly improve outcomes for patients with late-stage bowel cancer.
Dr Michelle McDonald and her team are in a unique position to examine how some drugs help to keep cancer cells in bone at bay.
This project has worked to improve treatments and reduce the major challenge of some breast cancer patients’ resistance to endocrine therapy and relapse.
Dr Wang and her team have identified a new treatment target for one of the most lethal forms of leukaemia.
Dr Micklethwaite has been developing myeloma-specific CAR T-cells – immune cells specifically designed to recognise and destroy myeloma cells.
Prof Tangye is studying patients with immune deficiencies and how this leads to the development of lymphoma cancers.
Professor Croucher and his team have demonstrated the potential of a newly approved treatment for osteoporosis to strengthen and rebuild bone damaged by myeloma.
Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.
This project will develop methods for upscaling CAR T-cell production in NSW – accelerating the introduction of this cutting-edge therapy and making treatment more affordable.
Associate Professor Holst’s team have been working on a new type of anti-cancer drug that can ‘starve’ prostate cancer cells and stop their growth.